Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

MEDIAN Technologies to take part in The Annual 2012 Conference of RSNA in Chicago

November 22, 2012 1:30 am | by The Associated Press | News | Comments

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Nov 22, 2012--Regulatory News: MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software developer and service provider for oncology clinical trials and routine radiological practice, will participate in the 98 th Annual Meeting of the...

Concord Medical to Hold Annual General Meeting on December 22, 2012

November 21, 2012 2:38 pm | by Bio-Medicine.Org | News | Comments

BEIJING, Nov. 21, 2012 /- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital,, today announced that it will hold its annual general meeting of sh...

ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment

November 21, 2012 2:31 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 21, 2012 /- ResMed Inc. (NYSE: RMD ) today announced that the dividend to be paid on December 18, 2012, to holders of Chess Depositary Instruments (CDIs) trading on the Australian Securities Exchange will be Australian dollar $0.01636 per CDI.  (Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO ) ResMed previously declared a quarterly dividend...

Advertisement

Computer-navigated total knee replacement provides no advantage over traditional surgical procedure

November 21, 2012 1:39 pm | by Bio-Medicine.Org | News | Comments

ROSEMONT, Ill., Nov. 21, 2012 /PRNewswire-USNewswire/ -- For many years, the use of computer-assisted navigation has been touted as improving the positioning, sizing and alignment of replacement knee joints, resulting in greater durability of joints and overall improvement in patient movement. However, new research published in the Journal of Bone and Joint Surgery (JBJS) found no differen...

Mauna Kea Technologies Announces the Signature of a Strategic Partnership With University of Edinburgh for Novel Optical Biopsy Device for Pulmonary Applications

November 21, 2012 11:45 am | by The Associated Press | News | Comments

Mauna Kea Technologies (EURONEXT PARIS: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced that it has entered into a research agreement through a collaboration negotiated by Edinburgh BioQuarter and the University of...

FDA slams St. Jude Medical over Durata pacemaker leads

November 21, 2012 11:29 am | by Mass Device | News | Comments

St. Jude Medical shares are down 11% today after the FDA releases a report slamming the company over its Durata pacemaker leads. The FDA yesterday released a report on a St. Jude Medical (NYSE:STJ) plant in Sylmar, Calif., that makes its Durata pacemaker leads, finding 11 problems with the plant after inspections in September and October. News Well, Cardiac Rhythm Management, Regulatory/Complianceread more

Boston Scientific lands Euro nod for extended heart implant battery life

November 21, 2012 11:29 am | by Mass Device | News | Comments

European regulators approve updated labeling for several of Boston Scientific's implantable cardiac devices to reflect battery life potentials that the company says double some rival devices. Medical devices giant Boston Scientific (NYSE:BSX) this week won CE Mark approval in the European Union for updated labeling on several models of its implantable cardiac devices in recognition of battery life projections of up to 10 years in some cases. News Well, Cardiac Implants, CE Mark, Regulatory/Complianceread more

Thoratec Presentation At Piper Jaffray 24th Annual Healthcare Conference To Be Webcast

November 21, 2012 11:25 am | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., Nov. 21, 2012 /- Thoratec Corporation (NASDAQ: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Piper Jaffray 24 th Annual Healthcare Conference on Tuesday, November 27. Gary F. Burbach, President and Chief Executive Officer, will provide an...

Advertisement

Mako Surgical closes $43 million public offering

November 21, 2012 10:29 am | by Mass Device | News | Comments

Florida surgical devices maker Mako Surgical closes an $40 million fundraising round with an extra $3 million in tow. Fort Lauderdale-based medical device maker Mako Surgical (NSDQ:MAKO) closed the books on a $40 million funding round with an extra $3 million in net proceeds, the company announced. Mako said last week that the offering, priced at $13.15 per share for more than 3 million shares, would go toward "commercialization infrastructure" and to cover other corporate expenses. News Well, Robotic Assisted Surgery, Wall Street Beatread more

Medtronic updates on Symplicity high blood pressure device

November 21, 2012 10:26 am | by Mass Device | News | Comments

Executives at Medtronic issue an update on the medical device company's Symplicity renal denervation device for treating high blood pressure. Medtronic (NYSE:MDT) executives yesterday updated analysts on its device for treating high blood pressure, a renal denervation system called Symplicity, laying out the timetable for its hypertension program. In renal denervation, a catheter is inserted in to the renal arteries to ablate the nerves lining those vessels, which play a role in regulating blood pressure. News Well, Clinical Trials, Hypertension, Renal, Wall Street Beatread more

Novel Mechanism Through Which Normal Stromal Cells Become Cancer-promoting Stromal Cells Identified

November 21, 2012 10:00 am | by AACR | News | Comments

Change in three microRNAs’ expression converted normal fibroblasts to cancer-associated fibroblasts. Restoring the pattern of microRNA expression reduced cancer-promoting qualities. Cytokines regulated by these specific microRNAs represent potential new targets for ovarian cancer treatment. PHILADELPHIA — New understanding of molecular changes that convert harmless cells surrounding ovarian cancer cells into cells that promote tumor growth [...]

Colorado Telehealth Network Signs Contract with GNAX Health to Provide Statewide Medical Image Archive and Exchange

November 21, 2012 9:44 am | by Bio-Medicine.Org | News | Comments

DENVER, Nov. 21, 2012 /- Summary:  The Colorado Telehealth Network (CTN) signed a contract today with GNAX Health to enable health care providers in Colorado to safely store and share medical images. GNAX Health is partnering with Acuo Technologies and Client Outlook to provide vendor-neutral archiving services and diagnostic-quality medical image viewing as part of the serv...

Chinese regulators pursue heavier penalties for medical device violations

November 21, 2012 9:29 am | by Mass Device | News | Comments

The State Food and Drug Administration (SFDA) of China has set new rules (translated via Google) effective January 1, 2013 that would mete out more severe punishment to medical device and pharmaceutical manufacturers for certain violations.

Cardium Therapeutics claims patent win over Boston Scientific

November 21, 2012 9:24 am | by Mass Device | News | Comments

Cardium Therapeutics says the European Patent Office hands it a win in a patent war with Boston Scientific over cardiovascular gene therapy technology. Legal News, News Well, Patent Infringementread more

CFS Conductive Foam Offered with UL94-V1 Rating

November 21, 2012 9:05 am | Leader Tech Inc. | Product Releases | Comments

Leader Tech announces that its CFS Conductive Foam material is now available with an optional UL94-V1 flammability rating. The new EMI shielding material from Leader is a great choice...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading